Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21316657 | 1.00 | PTGS1 (0.31) | PTGS1PTGS2 | |
| SCHEMBL21316656 | 0.97 | PTGS1 (0.32) | PTGS1PTGS2 | |
| SCHEMBL21316655 | 0.94 | PTGS1 (0.31) | PTGS1PTGS2 | |
| SCHEMBL20083579 | 0.91 | PTGS1 (0.32) | PTGS1PTGS2 | |
| SCHEMBL3921208 | 0.81 | PTGS1 (0.33) | PTGS1PTGS2 | |
| SCHEMBL4878967 | 0.81 | PTGS1 (0.35) | PTGS1PTGS2 | |
| SCHEMBL20478201 | 0.81 | PTGS1 (0.35) | PTGS1PTGS2 | |
| SCHEMBL16020793 | 0.81 | PTGS1 (0.35) | PTGS1PTGS2 | |
| SCHEMBL48081 | 0.81 | PTGS1 (0.35) | PTGS1PTGS2 | |
| SCHEMBL24499024 | 0.81 | PTGS1 (0.32) | PTGS1PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10400173-B2 | Siloxane-modified cyclotriphosphazene halogen-free flame retardant, preparation process and use thereof | SHENGYI TECHNOLOGY CO., LTD. (CN) | 2019-09-03 | — | — | US | disclosed |
| US-20180112133-A1 | SILOXANE-MODIFIED CYCLOTRIPHOSPHAZENE HALOGEN-FREE FLAME RETARDANT, PREPARATION PROCESS AND USE THEREOF | SHENGYI TECHNOLOGY CO., LTD. (CN) | 2018-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10400173-B2 | Siloxane-modified cyclotriphosphazene halogen-free flame retardant, preparation process and use thereof | PFAS, POLL, POLR1E | PTGS1 2214/4885PTGS2 2067/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.